Literature DB >> 21972210

Chronic lymphocytic leukemia--genomics lead the way.

Daniel Mertens, Lars Bullinger, Stephan Stilgenbauer.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21972210      PMCID： PMC3186299          DOI： 10.3324/haematol.2011.052175

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  20 in total

1.  Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations.

Authors:  Carsten Schwaenen; Michelle Nessling; Swen Wessendorf; Tatjana Salvi; Gunnar Wrobel; Bernhard Radlwimmer; Hans A Kestler; Christian Haslinger; Stephan Stilgenbauer; Hartmut Döhner; Martin Bentz; Peter Lichter
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-16       Impact factor: 11.205

2.  Analysis of 11q22-q23 deletion target genes in B-cell chronic lymphocytic leukaemia: evidence for a pathogenic role of NPAT, CUL5, and PPP2R1B.

Authors:  Claudia Kalla; Markus O Scheuermann; Ina Kube; Magdalena Schlotter; Daniel Mertens; Hartmut Döhner; Stephan Stilgenbauer; Peter Lichter
Journal:  Eur J Cancer       Date:  2007-04-20       Impact factor: 9.162

3.  Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival.

Authors:  Stephan Stilgenbauer; Sandrine Sander; Lars Bullinger; Axel Benner; Elke Leupolt; Dirk Winkler; Alexander Kröber; Dirk Kienle; Peter Lichter; Hartmut Döhner
Journal:  Haematologica       Date:  2007-08-01       Impact factor: 9.941

4.  Allelic silencing at the tumor-suppressor locus 13q14.3 suggests an epigenetic tumor-suppressor mechanism.

Authors:  Daniel Mertens; Stephan Wolf; Cordula Tschuch; Cora Mund; Dirk Kienle; Sibylle Ohl; Petra Schroeter; Frank Lyko; Hartmut Döhner; Stephan Stilgenbauer; Peter Lichter
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-09       Impact factor: 11.205

5.  Genomic aberrations and survival in chronic lymphocytic leukemia.

Authors:  H Döhner; S Stilgenbauer; A Benner; E Leupolt; A Kröber; L Bullinger; K Döhner; M Bentz; P Lichter
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

6.  Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14.

Authors:  Peter Ouillette; Harry Erba; Lisa Kujawski; Mark Kaminski; Kerby Shedden; Sami N Malek
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

7.  Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets.

Authors:  Laura J Rush; Aparna Raval; Pauline Funchain; Amy J Johnson; Lisa Smith; David M Lucas; Melania Bembea; Te-Hui Liu; Nyla A Heerema; Laura Rassenti; Sandya Liyanarachchi; Ramana Davuluri; John C Byrd; Christoph Plass
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

8.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.

Authors:  Michael Hallek; Bruce D Cheson; Daniel Catovsky; Federico Caligaris-Cappio; Guillaume Dighiero; Hartmut Döhner; Peter Hillmen; Michael J Keating; Emili Montserrat; Kanti R Rai; Thomas J Kipps
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

Review 9.  Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation.

Authors:  P Ghia; N Chiorazzi; K Stamatopoulos
Journal:  J Intern Med       Date:  2008-12       Impact factor: 8.989

10.  Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia.

Authors:  Aparna Raval; Stephan M Tanner; John C Byrd; Elizabeth B Angerman; James D Perko; Shih-Shih Chen; Björn Hackanson; Michael R Grever; David M Lucas; Jennifer J Matkovic; Thomas S Lin; Thomas J Kipps; Fiona Murray; Dennis Weisenburger; Warren Sanger; Jane Lynch; Patrice Watson; Mary Jansen; Yuko Yoshinaga; Richard Rosenquist; Pieter J de Jong; Penny Coggill; Stephan Beck; Henry Lynch; Albert de la Chapelle; Christoph Plass
Journal:  Cell       Date:  2007-06-01       Impact factor: 41.582
View more
  3 in total

1.  Activation of the NOTCH1 pathway in chronic lymphocytic leukemia.

Authors:  Valentina Gianfelici
Journal:  Haematologica       Date:  2012-03       Impact factor: 9.941

2.  Lack of Associations between TLR9 and MYD88 Gene Polymorphisms and Risk of Chronic Lymphocytic Leukemia

Authors:  Yasser B.M Ali; Rasha M Foad; Essam Abdel-Wahed
Journal:  Asian Pac J Cancer Prev       Date:  2017-12-29

3.  Mannose-binding lectin 2 (MBL2) gene polymorphisms do not influence frequency of infections in chronic lymphocytic leukemia patients.

Authors:  Katarina Holanda; Antonio Roberto Lucena-Araujo; Adônis Quintas; Taciana Mendonça; Aleide Lima; Luydson Richardson Vasconcelos; Patrícia Moura; Maria Cavalcanti; Cíntia Machado; Aderson Silva Araújo; Marcos Andre Bezerra
Journal:  Rev Bras Hematol Hemoter       Date:  2014
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.